Status:
UNKNOWN
Dexmedetomidine Versus Nalbuphine in Prevention of Emergence Agitation Following Adenotonsillectomy in Pediatrics
Lead Sponsor:
Ain Shams University
Conditions:
Emergence Delirium
Eligibility:
All Genders
2-5 years
Phase:
PHASE1
PHASE2
Brief Summary
The aim of the present study is to compare the effect of IV infusion 0.5 µg/kg dexmedetomidine and IV 0.1 mg/kg nalbuphine in preschool children for prevention of emergence agitation after adenotonsil...
Detailed Description
Consent will be obtained from legal guardian of children,patients will be randomized according to computer randomization to one of two groups, dexmedetomidine group (DEX)group who will receive 0.5 µg/...
Eligibility Criteria
Inclusion
- Children of (American Society of Anesthesiologist)ASA physical status grade I or II.
- Aged 2-5 years
- Undergoing elective adenotonsillectomy.
Exclusion
- History of hypersensitivity to the studied drug.
- Refusal of the legal guardian to participate in the study.
- Severely agitated child at induction of anesthesia
- Occurrence of postoperative bleeding at(Post Anesthesia Care Unit) PACU
Key Trial Info
Start Date :
March 5 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04058899
Start Date
March 5 2019
End Date
September 1 2019
Last Update
August 20 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain Shams University
Cairo, Egypt, 11566